facebook tracking

NPPA

NPPA FAQs on Trade Margin Rationalisation of Anti-Cancer Medicines


regulatory illustration
Importer & Manufacturer   |   Source: NPPA
Published On: 06-11-2026

Enforcement Date: 17 October, 2026
NPPA FAQs on Trade Margin Rationalisation of Anti-Cancer Medicines

The National Pharmaceutical Pricing Authority (NPPA) has issued FAQs explaining its initiative to cap trade margins at 30% for 137 specified non-scheduled anti-cancer medicines. Effective 9 November 2026, the measure aims to reduce excessive supply-chain markups and improve affordability. The FAQs clarify the medicines covered, pricing implications, responsibilities of hospitals and pharmacies, price-checking methods, and complaint mechanisms.


The FAQs provide guidance on NPPA’s trade margin rationalisation initiative, which caps trade margins at 30% for 137 specified non-scheduled anti-cancer medicines listed in Table B of the relevant notification. The revised pricing mechanism will take effect from 9 November 2026 and remain in force until further orders.


Key points include:

  1. The cap applies to both branded and generic versions of the covered formulations; it does not mean that every medicine will become 30% cheaper.
  2. Permissible MRPs may vary by brand, strength, dosage form and pack size, depending on the applicable pricing formula.
  3. Patients can check revised prices through medicine packaging, retailer or hospital price lists, manufacturer information, the NPPA website and Pharma Sahi Daam.
  4. Hospitals, medical institutions, retailers and dealers must comply with applicable pricing and price-display requirements. Hospitals and medical institutions must also prominently display revised prices on their websites.
  5. Patients can report overcharging through Pharma Sahi Daam, NPPA email or helpline, or the concerned State Drug Controller.


Applicable For: Importer & Manufacturer
Reference Number: NA Notification Link

Related Regulatory Updates

Contact us

Please feel free to talk to us if you have any questions. We endeavour to answer within 24 hours.